参考文献/References:
［1］Dean LE，Jones GT，Mac Donald AG，et al．Global prevalence of ankylosing spondylitis［J］．Rheumatology(Oxford)，2014，53(4)：650-657．
[2]Sieper J，Braun J，Kay J，et al．Sarilumab for the treatment of ankylosing spondylitis：results of a Phase II，randomised，double-blind，placebo-controlled study (ALIGN)［J］．Ann Rheum Dis，2015，74(6)：1051-1057．
[3]Robinson PC，Brown MA．The genetics of ankylosing spondylitis and axial spondyloarthritis［J］．Rheum Dis Clin North Am，2012，38(3)：539-553．
[4]Zhang L，Liu JL，Zhang YJ，et al．Association between HLA-B 27 polymorphisms and ankylosing spondylitis in Han populations：a meta-analysis［J］．Clin Exp Rheumatol，2011，29(2)：285-292．
[5]Cauli A，Dessole G，Vacca A，et al．Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression，which shows moderate variability over time［J］．Scandinavian Journal of Rheumatology，2012，41(3)：214-218．
[6]黄建民，李荣需，周玲，等．强直性脊柱炎与HLA-B27基因亚型动态定量表达的相关性研究［J］．中国医学创新，2013，10(32)：143-145．
Huang JM，Li RX，Zhou L，et al．Investigation of relationship between AS and HLA-B27 gene subtype quantative expression［J］．Medical Innovation of China，2013，10(32)：143-145．
[7]Jiang YT，Yang MC，Wu HS，et al．The relationship between disease activity measured by the BASDAI and psychological status，stressful life events，and sleep quality in ankylosing spondylitis［J］．Clinical Rheumatology，2015，34(3)：503-510．
[8]Pedersen SJ，Srensen IJ，Garnero P，et al．ASDAS，BASDAI and different treatment responses and their relation to biomarkers of inflammation，cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors［J］．Annals of the Rheumatic Diseases，2011，70(8)：1375-1381．
[9]Bettencourt BF，Rocha FL，Alves H，et al．Protective effect of an ERAP1 haplotype in ankylosing spondylitis：investigating non-MHC genes in HLA-B27-positive individuals［J］．Rheumatology(Oxford)，2013，52(12)：2168-2176．
[10]孙灵迪，梅传忠，王平均，等．PCR-SBT与IMS-ELISA法在强直性脊柱炎患者HLA-B27检测中的比较［J］．现代检验医学杂志，2015，30(2)：16-18．
Sun LD，Mei CZ，Wang PJ，et al．Comparison analysis of HLA-B27 detection by AS patients［J］．J Mod Lab Med，2015，30(2)：16-18．
[11]Sieper J，van der Heijde D，Dougados M，et al．Early response to adalimumab predicts long-term remission through 5 years of treatment in patients with ankylosing spondylitis［J］．Annals Rheumatic Diseases，2012，71(5)：700-706．
[12]吴丽娟，李茂圆，刘霞，等．外周血淋巴细胞HLA-B27表达强度与强直性脊柱炎临床分期的关系［J］．检验医学与临床，2014，11(21)：2971-2973．
Wu LJ，Li MY，Liu X，et al．Relationship between expression intensity of HLA-B27 in peripheral blood lymphocyte and clinical stage of ankylosing spondylitis［J］．Laboratory Medicine and Clinic，2014，11(21)：2971-2973．
[13]Yang T，Duan ZH，Wu SS，et al．Association of HLA-B27 genetic polymorphisms with ankylosing spondylitis susceptibility worldwide：a meta-analysis［J］．Modern Rheumatology，2014，24(1)：150-161．
[14]张志坚，奚永志，孙玉英．全基因组单核苷酸多态性与强直性脊柱炎遗传易感性的研究进展［J］．中华医学杂志，2011，91(18)：1289-1291．
Zhang ZJ，Xi YZ，Sun YY．Progress of genetic susceptibility of the whole genome single nucleotide polymorphism and ankylosing spondylitis［J］．National Medical Journal of China，2011，91(18)：1289-1291．
相似文献/References:
[1]王天菊,陈利萍,王小芳,等.WHO HLA命名委员会命名的新等位基因HLA-A*24:327序列分析及确认[J].现代检验医学杂志,2016,31(05):18.[doi:10.3969/j.issn.1671-7414.2016.05.005]
WANG Tian-ju,CHEN Li-ping,WANG Xiao-fang,et al.Sequence Analysis and Identification of A Novel
HLA-A* 24:327 Allele Been Designated by the HLA
Nomenclature Committee of WHO[J].Journal of Modern Laboratory Medicine,2016,31(05):18.[doi:10.3969/j.issn.1671-7414.2016.05.005]